Publicaciones en colaboración con investigadoras/es de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (20)

2023

  1. Blood RNA-Seq profiling reveals a set of circular RNAs differentially expressed in frail individuals

    Immunity and Ageing, Vol. 20, Núm. 1

  2. Executive functions and daily functioning in myotonic dystrophy type 1 ecological assessment with virtual reality

    Neuromuscular Disorders, Vol. 33, Núm. 12, pp. 917-922

2022

  1. A validated WAIS-IV short-form to estimate intellectual functioning in myotonic dystrophy type 1

    Neuromuscular Disorders, Vol. 32, Núm. 9, pp. 749-753

2021

  1. Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration

    Neuropathology and Applied Neurobiology, Vol. 47, Núm. 7, pp. 1092-1108

2020

  1. Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study

    Journal of Neuropsychology, Vol. 14, Núm. 1, pp. 121-134

  2. Neurodegeneration trajectory in pediatric and adult/late DM1: A follow-up MRI study across a decade

    Annals of Clinical and Translational Neurology, Vol. 7, Núm. 10, pp. 1802-1815

2019

  1. Proteolytic Degradation of Hippocampal STEP 61 in LTP and Learning

    Molecular Neurobiology, Vol. 56, Núm. 2, pp. 1475-1487

  2. Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1

    NeuroImage: Clinical, Vol. 24

  3. T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians

    Aging, Vol. 11, Núm. 22, pp. 10723-10741

2018

  1. Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old

    Frontiers in Aging Neuroscience, Vol. 10

  2. Pharmacogenetic modulation of STEP improves motor and cognitive function in a mouse model of Huntington's disease

    Neurobiology of Disease, Vol. 120, pp. 88-97

2016

  1. Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61) levels

    Journal of Neurochemistry, Vol. 136, Núm. 2, pp. 285-294

  2. SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent

    Scientific Reports, Vol. 6

2014

  1. Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats

    Neuropharmacology, Vol. 79, pp. 726-737

  2. Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis

    Biomarkers in Medicine, Vol. 8, Núm. 5, pp. 653-661

  3. Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa

    Revista de Neurologia, Vol. 58, Núm. 8, pp. 337-344

  4. Sustained Increase of PKA Activity in the Postcommissural Putamen of Dyskinetic Monkeys

    Molecular Neurobiology, Vol. 50, Núm. 3, pp. 1131-1141

2013

  1. Distinctive age-related temporal cortical thinning in asymptomatic granulin gene mutation carriers

    Neurobiology of Aging, Vol. 34, Núm. 5, pp. 1462-1468

2011

  1. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1812, Núm. 7, pp. 732-742

  2. Neurocognitive disorder detection based on feature vectors extracted from VBM analysis of structural MRI

    Computers in Biology and Medicine, Vol. 41, Núm. 8, pp. 600-610